PRF1 and neoplasm: Regardless of the mechanism of NK/CTL activation or the tumor-specific antigen recognized, tumor cell killing occurs through two major pathways: (1) by perforin and granzyme-containing lytic granules or (2) via death ligand cytokines of the TNF superfamily (Figure 1).